About Twilight Litaka Pharma
Twilight Litaka Pharma was a Healthcare company based in Mumbai (India) founded in 1974. It develops innovative technologies for drugs and formulations. It operates on a B2B model. Twilight Litaka Pharma has raised $56.21 million across 1 funding round from investors including ChrysCapital. Its Indian entity Twilight Litaka Pharma Limited reported revenue of ₹31.51 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Development and Formulation Technologies.
Company details
Twilight Litaka Pharma, founded in 1974 in Mumbai, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug development, and formulation technologies. Develops innovative technologies for drugs and formulations. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Mumbai, India
- Employees 1
- Stage Public
- SectorsHealthcare
- Website twilightlitaka.com
- Legal Name Twilight Litaka Pharma Limited
- Date of Incorporation 18 Jan, 1974
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹31.51 Cr
FY 2014 · -91% YoY
- Total Equity Funding$56.21M (USD)
in 1 rounds
- Latest Funding Round$56.21M (USD), Private Equity Round
Apr 2012
- Investors
- Employee Count1
Associated legal entities of Twilight Litaka Pharma
Twilight Litaka Pharma operates through Twilight Litaka Pharma Limited, a listed company (under liquidation). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2014) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Twilight Litaka Pharma Limited Listed CIN L24231MH1974PTC017139 | Under Liquidation | 18 Jan 1974 | Pune, Maharashtra | ₹31.5 Cr | 4 | View details |
Funding Insights of Twilight Litaka Pharma
Twilight Litaka Pharma has successfully raised a total of $56.21M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $56.21 million completed in April 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $56.21M
- Total Rounds 1
- Last Round Private Equity Round — $56.21M
- First Round $56.21M
(Apr 2012)
- Investors Count 1
All 1 funding rounds of Twilight Litaka Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2012 | $56.21M | Private Equity Round | – | ChrysCapital | – |
1 investors in total: 1 institutional.
Investors in Twilight Litaka Pharma
Twilight Litaka Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ChrysCapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment firm focusing on private equity in sectors like financial services and healthcare. | 1999 | chryscapital.com |
Investor details for Twilight Litaka Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Twilight Litaka Pharma Limited (Twilight Litaka Pharma)
Twilight Litaka Pharma Limited is the primary company behind Twilight Litaka Pharma. The board of Twilight Litaka Pharma Limited currently have 4 directors; the longest-serving is Avinash Shantaram Chandvankar, appointed in 2002. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Avinash Shantaram Chandvankar DIN 00128958 | Director | 20 Apr 2002 | 24 yrs 6 mo | Twilight Litaka Pharma Limited |
| Nainish Rajendra Bora DIN 00152040 | Whole-time director | 25 Mar 2005 | 21 yrs 6 mo | Twilight Litaka Pharma Limited |
| Gopal Kupposwami Ramourti DIN 00296595 | Managing Director | 30 Jun 2005 | 21 yrs 3 mo | Twilight Litaka Pharma Limited |
| Srinivasa Raghavan Mathurakavi Ayyangar DIN 00090266 | Director | 31 Dec 2005 | 20 yrs 9 mo | Twilight Litaka Pharma Limited |
Financials of Twilight Litaka Pharma
Figures of Twilight Litaka Pharma Limited, the primary company behind Twilight Litaka Pharma, for FY 2014. Revenue was ₹31.51 Cr (-91% year on year).
- ₹31.51 CrRevenue · FY 2014 · -91% YoY
- ₹12.39 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Twilight Litaka Pharma Limited are on its company page.
Detailed financial statements for Twilight Litaka Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Twilight Litaka Pharma
3 dated milestones of Twilight Litaka Pharma across 38 years, from founding to its latest funding, stage changes and deals.
- Founded Twilight Litaka Pharma is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $56.2M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Twilight Litaka Pharma
Complete news archive for Twilight Litaka Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Twilight Litaka Pharma
Twilight Litaka Pharma was founded in 1974 and raised its 1st funding round 38 years after it was founded.
Twilight Litaka Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Twilight Litaka Pharma is a funded company, having raised a total of $56.21M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $56.21M, raised on Apr 2012.
Twilight Litaka Pharma has 1 employees.
The primary company behind Twilight Litaka Pharma, Twilight Litaka Pharma Limited, reported revenue of ₹31.51 Cr for FY 2014, down 91% year on year.
Twilight Litaka Pharma, founded in 1974 in Mumbai, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug development, and formulation technologies. Develops innovative technologies for drugs and formulations. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Twilight Litaka Pharma has 1 investor. Key investors include ChrysCapital.
Twilight Litaka Pharma operates through Twilight Litaka Pharma Limited.
The legal entities of Twilight Litaka Pharma currently have 4 directors, including Srinivasa Raghavan Mathurakavi Ayyangar, Avinash Shantaram Chandvankar, Nainish Rajendra Bora and others.